Clinical Trials
11 trialsNCT05296304 2026-02-04
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT01578499 2021-01-05
ALCANZA
Takeda
Phase 3 Completed
NCT01134341 2019-12-18
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc.
Phase 1 Completed
NCT01007448 2019-11-12
Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)
Bausch Health Americas, Inc.
Phase 4 Completed
NCT00255801 2018-08-16
Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00056056 2018-07-09
Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated
NCT00178841 2016-02-17
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
Vanderbilt University
Phase 2 Completed
NCT00660231 2014-12-03
GemBex
University College, London
Phase 2 Completed
NCT00030589 2013-12-18
Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00322296 2013-04-16
Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis
Fox Chase Cancer Center
Phase 2 Terminated
NCT00306969 2006-03-27
Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
Boston University
Phase 1/2 Completed